We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medicare to Cover Edwards’ TAVR, Company Adjusts Sales Forecast
Medicare to Cover Edwards’ TAVR, Company Adjusts Sales Forecast
May 4, 2012
U.S. sales of Edwards’ Sapien transcatheter aortic valve replacement (TAVR) could reach as high as $240 million in 2012, buoyed by a federal decision that Medicare will pay for the medical device, effective immediately.